Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
VICTORY-S: lurasidone versus paliperidone switching followed by NEAR cognitive rehabilitation in schizophrenia
jRCTs031200338Active, not recruiting
- Sponsor
- Sumitomo Pharma
- Start
- Feb 2023
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Randomised, open-label trial in schizophrenia comparing Lurasidone then lurasidone + NEAR with Paliperidone then paliperidone + NEAR (2 arms). Primary endpoint: Change in BAC App composite T-score. Started Feb 2023; status: active, not recruiting.
02
Drugs
lurasidonepaliperidone
03
Conditions
schizophrenia
Beyond the preview
Go deeper on jRCTs031200338.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on jRCTs031200338.